Outcome of 2 Simplification Strategies for the Treatment of Human Immunodeficiency Virus Type 1 Infection-Reference-Cited by-同舟云学术

Outcome of 2 Simplification Strategies for the Treatment of Human Immunodeficiency Virus Type 1 Infection

Published:2003-07-01 Issue:1 Volume:37 Page:41-49
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Maggiolo Franco¹,Ripamonti Diego¹,Ravasio Laura¹,Gregis Giampietro¹,Quinzan Giampaolo¹,Callegaro Annapaola²,Arici Claudio¹,Suter Fredy¹

Affiliation:

1. Division of Infectious Diseases, Ospedali Riuniti, Bergamo, Italy

2. Microbiology and Virology Laboratory, Ospedali Riuniti, Bergamo, Italy

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/37/1/41/23992458/37-1-41.pdf

Reference14 articles.

1. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients;d'Arminio Monforte;AIDS,2000

2. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors;Carr;AIDS,1998

3. Vascular complications associated with use of HIV protease inhibitors [letter];Behrens;Lancet,1998

4. Lipodystrophy syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor;Rakotoambinina;J Acquir Immune Defic Syndr,2000

5. Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1 infected patients with undetectable plasma HIV-1 RNA;Clumeck;AIDS,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV;Medicine;2020-11-20

2. Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis;BMC Infectious Diseases;2019-05-30

3. A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study;HIV Medicine;2014-12-04

4. 48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-Analysis;PLoS ONE;2014-09-04

5. Virological efficacy of abacavir: systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2014-07-28